{"entity":{"type":"insider","cik":"0001569157","url":"/insider/0001569157","json_url":"/insider/0001569157.json","name":"Gershkowitz Jayne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2014-08-21","last":"2015-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Gershkowitz Jayne","source":"filing","n_filings":6,"first_seen":"2014-08-21","last_seen":"2015-07-01"}],"transactions":[{"id":8495258,"accession":"0001209191-15-058117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-058117","line_url":"/filing/0001209191-15-058117#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (SVP, Chief Patient Advocate)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Patient Advocate)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Patient Advocate","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10649.0,"shares_display":"10,649","price_per_share":13.9748,"price_display":"13.97","price_state":"stated","total_value":148817.6452,"total_display":"148,817.65","total_whole":"148,818","shares_owned_after":5693.0,"shares_owned_after_display":"5,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-01","scope":"insider"},{"id":8127586,"accession":"0001209191-15-042022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-042022","line_url":"/filing/0001209191-15-042022#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (SVP, Chief Patient Advocate)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Patient Advocate)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Patient Advocate","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.8389,"price_display":"10.84","price_state":"stated","total_value":108389.0,"total_display":"108,389.00","total_whole":"108,389","shares_owned_after":5693.0,"shares_owned_after_display":"5,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2015-05-12","scope":"insider"},{"id":8185408,"accession":"0001209191-15-029052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-029052","line_url":"/filing/0001209191-15-029052#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (VP, Patient Advocacy)","role_mark":"O","role_mark_label":"Officer (VP, Patient Advocacy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Patient Advocacy","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10648.0,"shares_display":"10,648","price_per_share":11.5109,"price_display":"11.51","price_state":"stated","total_value":122568.0632,"total_display":"122,568.06","total_whole":"122,568","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider"},{"id":6708545,"accession":"0001209191-14-055071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-055071","line_url":"/filing/0001209191-14-055071#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (VP, Patient Advocacy)","role_mark":"O","role_mark_label":"Officer (VP, Patient Advocacy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Patient Advocacy","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","total_whole":"35,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"},{"id":6708543,"accession":"0001209191-14-055071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-055071","line_url":"/filing/0001209191-14-055071#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (VP, Patient Advocacy)","role_mark":"O","role_mark_label":"Officer (VP, Patient Advocacy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Patient Advocacy","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","total_whole":"35,000","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"},{"id":7015495,"accession":"0001209191-14-054452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-054452","line_url":"/filing/0001209191-14-054452#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (VP, Patient Advocacy)","role_mark":"O","role_mark_label":"Officer (VP, Patient Advocacy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Patient Advocacy","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-25","filed_date":"2014-08-26","scope":"insider"},{"id":7015493,"accession":"0001209191-14-054452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-054452","line_url":"/filing/0001209191-14-054452#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (VP, Patient Advocacy)","role_mark":"O","role_mark_label":"Officer (VP, Patient Advocacy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Patient Advocacy","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-25","filed_date":"2014-08-26","scope":"insider"},{"id":7094485,"accession":"0001209191-14-053862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-053862","line_url":"/filing/0001209191-14-053862#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (VP, Patient Advocacy)","role_mark":"O","role_mark_label":"Officer (VP, Patient Advocacy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Patient Advocacy","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6080.0,"shares_display":"6,080","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":32832.0,"total_display":"32,832.00","total_whole":"32,832","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-21","scope":"insider"},{"id":7094483,"accession":"0001209191-14-053862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-053862","line_url":"/filing/0001209191-14-053862#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001569157","owner_name":"Gershkowitz Jayne","owner_display_name":"Gershkowitz Jayne","owner_url":"/insider/0001569157","role":"Officer (VP, Patient Advocacy)","role_mark":"O","role_mark_label":"Officer (VP, Patient Advocacy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Patient Advocacy","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6080.0,"shares_display":"6,080","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":32832.0,"total_display":"32,832.00","total_whole":"32,832","shares_owned_after":56080.0,"shares_owned_after_display":"56,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Officer (SVP, Chief Patient Advocate)","n_filings":6,"first_seen":"2014-08-21","last_seen":"2015-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001569157","retrieved_at":"2026-08-26T07:43:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}